Nanopore-Based Neurotransmitter Detection: Advances, Challenges, and Future Perspectives

Area of Science:

• Neuroscience
• Bioengineering
• Nanotechnology

Background:

• Neurotransmitters are vital for brain function, and their imbalance is linked to neurological and neuropsychiatric disorders.
• Disruptions in neurotransmitter homeostasis are implicated in diseases such as Alzheimer's, Parkinson's, epilepsy, schizophrenia, depression, and ALS.
• Current diagnostic methods require improvement for early detection and personalized treatment.

Purpose of the Study:

• To review the role of neurotransmitters in neurological disorders.
• To highlight advances in nanopore-based neurotransmitter detection technologies.
• To discuss the potential of nanopore sensing for diagnostics and therapeutics.

Main Methods:

• Review of recent literature on nanopore-based sensing for neurotransmitter detection.
• Exploration of solid-state nanopores (SSNs) for their sensitivity and real-time monitoring capabilities.
• Examination of nanopipettes for their high spatial resolution and real-time neurotransmitter analysis.

Main Results:

• Solid-state nanopores (SSNs) demonstrate high sensitivity and durability for real-time neurotransmitter monitoring.
• Nanopipettes offer high spatial resolution for precise neurotransmitter detection.
• Nanopore technology shows promise for integration into diagnostic frameworks.

Conclusions:

• Nanopore sensing, utilizing SSNs and nanopipettes, can revolutionize neurotransmitter analysis.
• This technology holds significant potential for early disease detection and personalized therapeutic strategies.
• Further advancements in sensitivity, stability, and reproducibility are needed for widespread clinical application.